Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,976–3,000 of 7,816 matching trials · page 120 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Effect of Combination of Mediterranean Diet and Oleocanthal in Patients with Mild Cognitive Impairment NCT06705738 SUPOL; Dietary Pattern: MeDi Runs in: Greece · 2 sites |
NA other |
ACTIVE_NOT_RECRUITING | 200 | Aristotle University Of Thessaloniki OTHER |
2024-11-26 |
|
A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach NCT06706687 DISBAND protocol Runs in: Italy · 1 site |
NA other |
RECRUITING | 210 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico OTHER |
2024-11-26 |
|
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)" NCT03890861 Physical activity; Successful Aging Runs in: United States · 1 site |
NA other |
RECRUITING | 125 | Pennington Biomedical Research Center OTHER |
2024-11-25 |
|
Longitudinal Observational Biomarker Study NCT05204940 Mechanisms of Late life depression (LLD)-dementia through functiona... Runs in: Canada; United States · 5 sites |
NA other |
COMPLETED | 506 | Centre for Addiction and Mental Health OTHER |
2024-11-25 |
|
RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT) NCT05531591 Aripiprazole Augmentation; Bupropion Augmentation; Switch to buprop... Runs in: Canada; United States · 4 sites |
PHASE4 other |
COMPLETED | 87 | Centre for Addiction and Mental Health OTHER |
2024-11-25 |
|
Ruijin Neurobank of Alzheimer's Disease and Dementia NCT05623124 No intervention Runs in: China · 1 site |
NA other |
RECRUITING | 400 | Ruijin Hospital OTHER |
2024-11-25 |
|
Modified Ketogenic Diet in Amnestic Mild Cognitive Impairments NCT06444568 Dietary Intervention Runs in: Turkey (Türkiye) · 1 site |
NA other |
UNKNOWN | 36 | Saglik Bilimleri Universitesi OTHER |
2024-11-25 |
|
Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease NCT05887674 Diet intervention; Exercise; Cognitive training Runs in: China · 1 site |
NA other |
RECRUITING | 180 | Ruijin Hospital OTHER |
2024-11-22 |
|
Nut Supplementation to Mitigate Post-stroke Cognitive Decline NCT05902767 Nuts; Control Runs in: Australia · 1 site |
NA other |
SUSPENDED | 10 | Monash University OTHER |
2024-11-22 |
|
Alzheimer's Disease Neuroimaging Initiative 2 NCT01231971 Florbetapir; Flortaucipir Runs in: Canada; United States · 58 sites |
NA other |
COMPLETED | 1,182 | University of Southern California OTHER |
2024-11-21 |
|
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) NCT02099123 Atorvastatin; Placebo (for Atorvastatin) Runs in: Australia · 6 sites |
PHASE4 other |
ACTIVE_NOT_RECRUITING | 9,971 | Monash University OTHER |
2024-11-21 |
|
The Genetic and Affective Prediction Study NCT02625818 Runs in: Norway · 1 site |
NA other |
COMPLETED | 400 | St. Olavs Hospital OTHER |
2024-11-21 |
|
Deprescribing Antipsychotics in Long-Term Care NCT02958800 Intervention Runs in: Canada · 1 site |
NA other |
COMPLETED | 6 | McMaster University OTHER |
2024-11-21 |
|
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial NCT04259047 Diabetes Regulation for Eyesight and Memory; Enhanced Usual Care Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 145 | Thomas Jefferson University OTHER |
2024-11-21 |
|
Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment NCT06192433 High-frequency repetitive transcranial magnetic stimulation (40Hz);... Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 18 | Taipei Hospital, Ministry of Health and Welfare OTHER |
2024-11-21 |
|
Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study NCT06699992 Blood biomarkers quantification Runs in: Italy · 1 site |
NA other |
UNKNOWN | 1,000 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS OTHER |
2024-11-21 |
|
Effects of a Psychiatric Intensive Care Unit NCT00184119 Psychiatric Intensive Care Unit; Care in whole acute unit Runs in: Norway · 1 site |
NA other |
COMPLETED | 118 | Norwegian University of Science and Technology OTHER |
2024-11-20 |
|
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) NCT01767909 Insulin (Humulin® R U-100); Placebo Runs in: United States · 25 sites |
PHASE2|PHASE3 other |
COMPLETED | 240 | University of Southern California OTHER |
2024-11-20 |
|
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type NCT03393520 Placebo; AVP-786 Runs in: Australia; Bulgaria; Czechia; France; Hungary; Italy; Pol... · 211 sites |
PHASE3 other |
COMPLETED | 601 | Otsuka Pharmaceutical Development & Commercialization, Inc. INDUSTRY |
2024-11-20 |
|
An Observational Study of Patients Living With Chronic Neurological Diseases NCT05796037 |
NA other |
NOT_YET_RECRUITING | 1,500,000 | Target PharmaSolutions, Inc. INDUSTRY |
2024-11-20 |
|
Agitation in the Acute Psychiatric Department NCT01415323 Runs in: Norway · 1 site |
NA other |
COMPLETED | 384 | Norwegian University of Science and Technology OTHER |
2024-11-19 |
|
Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease NCT06694597 Astragalus Membranaceus Root Runs in: China · 1 site |
PHASE2 other |
COMPLETED | 76 | Fujian Medical University Union Hospital OTHER |
2024-11-19 |
|
Personalized Virtual Environments for Managing Responsive Behaviors in Cognitively Impaired Patients: a Feasibility Study NCT06693193 Immersive Virtual Reality Runs in: Italy · 1 site |
NA other |
NOT_YET_RECRUITING | 10 | Fondazione Bruno Kessler OTHER |
2024-11-18 |
|
Huntington's Disease and Pain NCT06693466 Facial expression block; Conditioned pain modulation block; Pain fa... Runs in: Netherlands · 1 site |
NA other |
NOT_YET_RECRUITING | 20 | Leiden University Medical Center OTHER |
2024-11-18 |
|
Improving Aging in Place in Subsidized Housing NCT04212442 Independent Living Program for Affordable Housing. Runs in: United States · 13 sites |
NA other |
COMPLETED | 75 | University of Pennsylvania OTHER |
2024-11-15 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial